Related Experiment Video
Updated: Jan 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Willingness to switch to injectable cabotegravir among oral PrEP users in Durban, South Africa
Tanuja N Gengiah1,2, Vaishnavi Naidoo1, Nothile Dlamini1
1Center for the AIDS Programme of Research in South Africa, Durban, South Africa.
Background:
Adherence to daily oral pre-exposure prophylaxis (PrEP) is challenging. Long-acting injectable cabotegravir (CAB-LA), administered every two months, may improve adherence.
Aim:
To assess willingness to switch from oral PrEP to CAB-LA among adult PrEP users.
Setting:
PrEP users were recruited from two public-sector primary health care clinics in Durban, South Africa.
Methods:
A cross-sectional survey assessed oral PrEP use and related challenges. After providing information on CAB-LA, participants' willingness to switch was evaluated. Descriptive statistics summarized data, and logistic regression identified factors associated with willingness to switch.
Results:
Of 126 participants, the median age was 28 years (IQR: 32-33), 88.1% were women, 96.0% identified as black African, and 83.3% were isiZulu speakers. Most were heterosexual (86.5%), 72.2% had tertiary education, and 38.1% were employed. Median oral PrEP duration was 365 days. While 92.1% reported oral PrEP fit their lifestyle, only 51.6% adhered consistently. Awareness of CAB-LA was low (8.7%), but 74.0% were willing to switch to improve adherence. Concerns about CAB-LA included injection site reactions (53.9%), systemic side effects (57.2%), and cost (82.6%). Longer-term oral PrEP users (> 1 year) had lower odds of willingness to switch (aOR: 0.36; 95% CI: 0.15-0.85; p = 0.019).
Conclusion:
Although oral PrEP was lifestyle-compatible, adherence was inconsistent. Most participants expressed willingness to switch to CAB-LA, but findings should be interpreted cautiously given study limitations. Targeted education may support longer-term oral PrEP users hesitant to switch.
Contribution:
This study highlights adherence challenges with oral PrEP and supports interest in longer-acting injectable alternatives.
Related Concept Videos
Subviral Agents
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Bioequivalence studies: Biowaivers
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

